Panorama of the headic

Armodafinil is the active ingredient often sold under trade names such as Waklert. It belongs to the eugeroic class, medicines that promote wakefulness by acting on the central nervous system.

Commonly available strengths include a 150 mg tablet, although specific pack sizes and brands vary by supplier. Armodafinil is used to reduce excessive daytime sleepiness in adults with certain sleep disorders. How the product is licensed, supplied and labelled will depend on the manufacturer besides the rules in the United Kingdom.

Swiftly navigate the site: for guidance on dosing go to How to Take, for important safety information resources see Notice: Guarding measures and Warning bulletins, and for cost details visit Costs of goods in the United Kingdom. For legal and import rules consult UK Legal and Regulatory counsel Standing.

Indicia and Primary Uses

Armodafinil is prescribed to improve wakefulness in adults who suffer from excessive sleepiness associated with particular diagnoses. Typical licensed or common hints include:

  • A chronic sleep disorder named narcolepsy to increase daytime alertness and reduce unintended sleep episodes
  • Shift work sleep disorder, taken to help maintain alertness during scheduled night or early morning shifts
  • Persistent daytime sleepiness despite treatment for obstructive sleep apnoea, when primary therapy such as CPAP does not fully resolve symptoms

Some clinicians may consider off-label uses, for example in selected cases of chronic fatigue, attention difficulties or as adjunctive therapy in mood disorders. Off-label prescribing requires specialist judgement, documentation and surveillance of system activity. Athletes should review anti-doping rules before using this class of medicines; see legal standing to learn more, visit our information page.

How to Take Properly

Always follow the instructions from your prescriber. Do not increase the dose or continue treatment longer than recommended without medical advice.

  • Narcolepsy as a neurological sleep disorder and residual sleepiness from OSA: a common approach is 150 mg once each morning, though individual dosing can differ.
  • Shift work sleep disorder: usually given as a single 150 mg dose about one hour before starting the work shift.
  • Review schedule: prescribers often reassess benefit and side effect risks within approximately 12 weeks of starting therapy.
  • Taking the tablet: swallow with water. Avoid late day dosing because insomnia is a frequent problem when taken late.

Certain patient groups such as those with impaired liver function, older adults or people sensitive to stimulant effects may require dose reductions. Do not drive or operate heavy machinery until you know how the medicine affects you. See Safety General Alert signals and Safety measures to safeguard safety.

Warning alerts and Cautions

Prestart armodafinil, inform your prescriber about any heart disease, psychiatric history, pregnancy plans, breastfeeding and all current medicines. Critical safety guidelines include:

  • Neuropsychiatric concerns: some patients report agitation, anxiety, irritability or dizziness. Rarely, more severe psychiatric events such as psychosis, mania or suicidal ideation have occurred. Report any changes in mood or behaviour promptly.
  • Cardiovascular monitoring: small increases in blood pressure or heart rate have been observed. People with uncontrolled hypertension, arrhythmias or significant cardiac disease should have specialist assessment and monitoring.
  • Severe skin and hypersensitivity reactions: if you develop a widespread rash, blistering, sores in the mouth or fever, stop treatment and seek urgent medical care.
  • Gestation and nursing: use only after specialist consultation. Armodafinil may reduce the effectiveness of some hormonal contraceptives; see Drug Interaction Effects.
  • Alcoholic content and other stimulants: combining with alcohol or recreational stimulants can increase undesired consequences and reduce overall benefit.
  • Fitness to drive: if excessive daytime sleepiness affects your ability to drive you must follow DVLA rules and not drive while sleepy; see UK Legislation and Regulation Status.
  • Age considerations: armodafinil is not routinely recommended for children and dose adjustments may be necessary in older adults.

Conditions precluding use

  • Known allergy or hypersensitivity to armodafinil, modafinil or any excipient in the tablet
  • Significant structural heart disease where stimulant effects could cause harm, unless a cardiology specialist advises it is safe

Provide a full medical history to your prescriber so that potential certain medical scenarios that disallow use can be checked against other conditions and medicines you take.

Possible treatment related latent effects

Many people tolerate armodafinil well, but some adverse reactions are common. Typical adverse reactions include:

  • Headache syndrome
  • Problems with sleep or insomnia
  • Nausea with a sick stomach
  • Giddy feeling
  • Anxiety, nervousness or restlessness

Not commonly seen complaints may include dry mouth, reduced appetite, palpitations, tremor and irritability. Seek urgent medical care if you experience any of the following serious signs:

  • Widespread blistering, peeling skin or mouth ulcers
  • Chest pain, sudden shortness of breath or fainting
  • New hallucinations, severe changes in thinking or suicidal thoughts

Drug Interaction Precautionary measures

Armodafinil affects metabolic enzymes and can alter the blood levels of other medicines. Check with your prescriber or pharmacist for personalised advice. High priority interplay between partiess are the heartbeat of social platforms. include:

  • CYP3A4 inhibitors (for example ketoconazole, itraconazole, clarithromycin) may increase armodafinil exposure and risk of harmful effects.
  • CYP3A4 inducers such as carbamazepine, rifampicin and Hypericum perforatum can reduce armodafinil concentrations and its effectiveness.
  • Medicines metabolised by CYP2C19 (for example omeprazole, diazepam and some antiepileptics) may have changed levels when coadministered with armodafinil; ongoing monitoring or dose adjustments might be required.
  • Hormonal contraceptives containing ethinylestradiol may be less effective. Use an additional reliable non-hormonal contraceptive while taking armodafinil and for two months after stopping.
  • An anticoagulant example is warfarin. and some antidepressants may need closer health monitoring because metabolic real time the interaction between participantss enable quick problem solving. can alter their activity.
  • Avoid mixing with alcohol and recreational stimulants as these combinations can increase adverse reactions.

Missed medication dose

If you forget to take your dose, take it as soon as you remember unless your next dose is due soon. Do not take two doses at the same moment to make up for a the dose was skipped. If in doubt, contact your prescriber or pharmacist for advice.

An non-fatal overdose event

Symptoms of an a drug overdose case may include agitation, severe restlessness, confusion, hallucinations, tremor, nausea, vomiting and a rapid heart rate. If you suspect an a drug overdose case or someone is severely unwell, go to the nearest emergency department or call 999. For non-emergency advice in England call NHS 111 and inform your prescriber.

Online keep your items in secure storage until you need them.

  • Keep in a cool, dry place, ideally between 20 and 25 C, away from direct heat and moisture.
  • Store medicines in their original packaging and keep out of sight and reach of children.
  • Do not use after the expiry date shown on the pack label.

A Study of Secondary options and Comparisons

If armodafinil is unsuitable, unavailable, or not funded, clinicians in the UK can consider other options. Choice depends on diagnosis, coexisting health problems and funding arrangements. Popular substitutes include:

  • Modafinil (for example generic modafinil or branded forms such as Modalert) - a closely related medicine usually given at 100 to 200 mg each morning and often easier to obtain with a UK marketing authorisation.
  • Solriamfetol (Sunosi) - a norepinephrine and dopamine reuptake inhibitor licensed for excessive daytime sleepiness in narcolepsy and OSA; requires blood pressure vigilant monitoring and is typically more expensive.
  • Pitolisant (Wakix) - a histamine H3 receptor antagonist/inverse agonist used for narcolepsy; dosing is titrated and social conversational exchanges influence perceptions and decisions. should be checked.
  • Central nervous system stimulants such as methylphenidate - sometimes used by specialists, but these are controlled drugs with tighter prescribing controls and tangible potential for misuse.

Choosing the right therapy involves weighing expected benefit against the exchange that happens when people meet risk, comorbidities and whether NHS funding or specialist approval will be required. See Current prices in the United Kingdom for a brief cost comparison.

UK Pricing Guide - Rough Guide

Private retail prices change frequently and vary by brand, pack size and supplier. The figures below are tentative price framework in Great Britain Pounds (GBP) for packs around 28 to 30 tablets.

  • Armodafinil 150 mg (Waklert or unlicensed equivalents): approximately 45 to 120 GBP per pack, depending on supplier and whether the product is an unlicensed special.
  • Modafinil 100-200 mg (generic or branded): about 30 to 90 GBP per pack.
  • Solriamfetol (Sunosi) 75-150 mg: commonly in the 140 to 250 GBP range per pack.
  • Pitolisant (Wakix): often costs in excess of 200 GBP depending on dose adjustment through titration needs.

If treatment is provided on the NHS along with the indication is approved, prescriptions in England are charged at the standard prescription item rate (around 9 to 10 GBP per item at the time of writing). Prescription charge systems differ in Scotland, Wales and Northern Ireland. Not all products or markers pointing to are routinely funded and specialist approval may be required.

Prices can fluctuate. Confirm current costs with your local pharmacy, clinic or supplier before purchasing.

Additional aspects about Waklert